Sign In
NASDAQ:CSBR
Champions Oncology Stock News
$4.61
+0.270 (+6.22%)
At Close: Dec 06, 2024
Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024
04:30pm, Thursday, 05'th Dec 2024
HACKENSACK, NJ / ACCESSWIRE / December 5, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will re
Champions Oncology Announces Agreement with Weill Cornell Medicine
10:55am, Wednesday, 16'th Oct 2024
HACKENSACK, NJ / ACCESSWIRE / October 16, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, is pleased to announce a licensing agre
Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript
08:52pm, Wednesday, 11'th Sep 2024
Champions Oncology, Inc. (NASDAQ:CSBR ) Q1 2025 Earnings Conference Call September 11, 2024 4:30 PM ET Company Participants Ronnie Morris - Chief Executive Officer David Miller - Chief Financial Offic
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million
04:00pm, Wednesday, 11'th Sep 2024
HACKSENSACK, NJ / ACCESSWIRE / September 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, toda
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024
04:00pm, Monday, 09'th Sep 2024
HACKENSACK, NJ / ACCESSWIRE / September 9, 2024 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report i
Champions Oncology Reports Quarterly Revenue of $14.0 Million
04:00pm, Thursday, 18'th Jul 2024
Annual Revenue of $50.2 Million HACKENSACK, NJ / ACCESSWIRE / July 18, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, today anno
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024
04:05pm, Thursday, 11'th Jul 2024
HACKENSACK, NJ / ACCESSWIRE / July 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will repor
Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
09:00am, Tuesday, 04'th Jun 2024
HACKENSACK, NJ / ACCESSWIRE / June 4, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, has announced a strategic partnership with
Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript
07:21pm, Tuesday, 12'th Mar 2024
Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript
Champions Oncology Reports Quarterly Revenue of $12.0 Million
04:30pm, Tuesday, 12'th Mar 2024
HACKENSACK, NJ / ACCESSWIRE / March 12, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today ann
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
09:00am, Thursday, 07'th Mar 2024
HACKENSACK, NJ / ACCESSWIRE / March 7, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, announced
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
04:35pm, Wednesday, 06'th Mar 2024
HACKENSACK, NJ / ACCESSWIRE / March 6, 2024 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its f
Champions Oncology, Inc. (CSBR) Q2 2024 Earnings Call Transcript
05:54pm, Tuesday, 12'th Dec 2023
Champions Oncology, Inc. (NASDAQ:CSBR ) Q2 2024 Earnings Conference Call December 12, 2023 4:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Operator Greetings. Welcome to the Cha
Champions Oncology Reports Quarterly Revenue of $11.6 Million
04:00pm, Tuesday, 12'th Dec 2023
HACKENSACK, NJ / ACCESSWIRE / December 12, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023
04:30pm, Monday, 04'th Dec 2023
HACKENSACK, NJ / ACCESSWIRE / December 4, 2023 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report it
